| P50 | author | Joshua L Everson | Q56882318 |
| | Robert J. Lipinski | Q56882322 |
| | Ariel F Martinez | Q61468811 |
| | Yu Abe | Q82299218 |
| | Kathleen K Sulik | Q114411919 |
| P2093 | author name string | Maximilian Muenke | |
| | Jerrold M Ward | |
| | Benjamin D Solomon | |
| | David E Kleiner | |
| | Paul Kruszka | |
| | Ramon Bataller | |
| | Karin Weiss | |
| | Maria J Guillen-Sacoto | |
| P2860 | cites work | Non-alcoholic fatty liver disease: what the clinician needs to know | Q24563068 |
| | The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis | Q26777980 |
| | Genetic background in nonalcoholic fatty liver disease: A comprehensive review | Q26780248 |
| | Lessons from mouse models of high-fat diet-induced NAFLD | Q26829532 |
| | Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase | Q28191295 |
| | The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity | Q28241306 |
| | Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development | Q28301976 |
| | Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas | Q28649881 |
| | Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 |
| | Role of GLI2 in hypopituitarism phenotype | Q30933565 |
| | Genesis of teratogen-induced holoprosencephaly in mice | Q34038364 |
| | Variations in body weight, food intake and body composition after long-term high-fat diet feeding in C57BL/6J mice | Q34270440 |
| | Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver | Q34565218 |
| | The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or GLI2 haploinsufficiency in the mouse. | Q35107351 |
| | Cell-autonomous activation of Hedgehog signaling inhibits brown adipose tissue development | Q35549055 |
| | Overweight in mice and enhanced adipogenesis in vitro are associated with lack of the hedgehog coreceptor boc. | Q35630797 |
| | Hedgehog secretion and signal transduction in vertebrates | Q36002803 |
| | Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets | Q36104399 |
| | Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications | Q36304061 |
| | Human sulfotransferases and their role in chemical metabolism. | Q36328535 |
| | Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease | Q36402141 |
| | Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease | Q36723148 |
| | Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. | Q36903660 |
| | Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis. | Q36908863 |
| | Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features | Q37089385 |
| | Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Q37284612 |
| | Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice | Q37349441 |
| | The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis | Q37411003 |
| | Gli2 gene-environment interactions contribute to the etiological complexity of holoprosencephaly: evidence from a mouse model. | Q37425971 |
| | From the metabolic syndrome to NAFLD or vice versa? | Q37703968 |
| | Hedgehog signaling in the liver | Q37811158 |
| | Roles of PPARs in NAFLD: potential therapeutic targets | Q37953148 |
| | p53 mutations in cancer | Q38069463 |
| | From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. | Q38080109 |
| | The genetics of NAFLD. | Q38141714 |
| | Fatty acid binding proteins: tissue-specific functions in health and disease | Q38185564 |
| | Phospholipid transfer protein in diabetes, metabolic syndrome and obesity | Q38238300 |
| | Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin | Q38289039 |
| | Inflammasome activation and function in liver disease | Q38521274 |
| | The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2. | Q38588336 |
| | Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Q38680300 |
| | Mechanisms of HBV-induced hepatocellular carcinoma. | Q38809557 |
| | The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH. | Q38851742 |
| | Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. | Q39260254 |
| | Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. | Q39829317 |
| | Inactivation of p16INK4 in hepatocellular carcinoma | Q41172497 |
| | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management | Q41725283 |
| | Hedgehog signaling plays a conserved role in inhibiting fat formation | Q42806335 |
| | White-to-brown metabolic conversion of human adipocytes by JAK inhibition | Q42972519 |
| | Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice | Q43109145 |
| | Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps | Q46384136 |
| | Genotypic and phenotypic analysis of 396 individuals with mutations in Sonic Hedgehog | Q48442390 |
| | Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma. | Q51389967 |
| | Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis | Q61756898 |
| | Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests | Q62617432 |
| | Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues | Q73043566 |
| | Germ-line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma | Q73420901 |
| | p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma | Q77917928 |
| P433 | issue | 4 | |
| P304 | page(s) | 809-817 | |
| P577 | publication date | 2017-06-21 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Human germline hedgehog pathway mutations predispose to fatty liver | |
| P478 | volume | 67 | |